Table 1 Description of RSBCS programmes.
From: The cost-effectiveness of risk-stratified breast cancer screening in the UK
Regimen | Description of risk groupings | Screening programmes offered to woman in the risk groups |
|---|---|---|
BRAID 1 | (1) Breast imaging reporting and data system (BI-RADS) classification A&B or (2) BI-RADS classification C&D | (1) Triennial mammogram (MAM), or (2) additional 18-monthly automated ultrasound (AUS) |
BRAID 2 | (1) BI-RADS A&B or (2) BI-RADS C&D | (1) Triennial MAM, or (2) additional 18-monthly contrast-enhanced spectral MAM (CESM) |
BRAID 3 | (1) BI-RADS A&B or (2) BI-RADS C&D | (1) Triennial MAM, or (2) additional 18-monthly abbreviated Magnetic Resonance Imaging (AMRI) |
ASSURE 1 | (1) < 3.5% Tyrer–Cuzick (TC), (2) 3.5% - 8% TC or (3) > 8% TC | (1) Triennial MAM, (2) biennial MAM, or (3) annual MAM |
ASSURE 2 | (1) Lowest TC risk tertile, (2) middle TC tertile or (3) highest TC risk tertile | (1) Triennial MAM, (2) biennial MAM, or (3) annual MAM |
ASSURE 3 | (1) Volumetric Breast Density (VBD) 1 & 2, (2) VBD 3 & 4 or (3) VBD 3&4 and >8% TC | (1) Triennial MAM, (2) triennial MAM with handheld ultrasound (HUS), or (3) triennial MAM with MRI |
ASSURE 4 | (1) < 3.5% TC and VBD 1&2, (2) < 3.5% TC and VBD 3&4, (3) 3.5–8% TC and VBD 1&2, (4) 3.5–8% TC and VBD 3&4, (5) > 8% TC and VBD 1&2 or (6) > 8% TC and VBD 3&4 | (1) Triennial MAM, (2) triennial MAM with HUS, (3) biennial MAM, (4) biennial MAM with HUS, (5) annual MAM, or (6) annual MAM with HUS |
PROCAS | (1) Age 35–49 y and >2.5% TC, (2) age 45–49 y and >1.5% TC, (3) age 50 and above and < 1.5% TC, (4) age 50 and above and 1.5–2.5% TC, (5) age 50 and above and 2.5–5% TC or (6) age 50 and above and >5% TC | (1) Annual MAM to age 50, (2) annual MAM to age 50, (3) no screening, (4) triennial MAM, (5) biennial MAM, or (6) annual MAM |
